<?xml version="1.0" encoding="UTF-8"?>
<p>RBP4 is a novel adipocytokine (adipocyte-secreted hormone), which shows upregulation in insulin-resistant animal models. In the clinical study, it is reported that the RBP4 level is higher in type 2 DM, gestational DM, and metabolic syndrome patients [
 <xref rid="B30" ref-type="bibr">30</xref>, 
 <xref rid="B31" ref-type="bibr">31</xref>]. However, in a study reported by Krill et al., it was found the RBP concentrations measured in DM serum samples were significantly lower than those in the healthy group [
 <xref rid="B32" ref-type="bibr">32</xref>–
 <xref rid="B34" ref-type="bibr">34</xref>]. Also, in another report, the mean serum vitamin A and RBP levels were significantly lower in the insulin-dependent diabetes mellitus (IDDM) patients. The linear regression between vitamin A and RBP levels was statistically significant [
 <xref rid="B35" ref-type="bibr">35</xref>]. In our study, the RBP4 level was downregulated in DM group. However, the role of RBP4 in DM is still challenged. 
</p>
